1. Home
  2. BIOX vs ELDN Comparison

BIOX vs ELDN Comparison

Compare BIOX & ELDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bioceres Crop Solutions Corp.

BIOX

Bioceres Crop Solutions Corp.

HOLD

Current Price

$1.31

Market Cap

109.2M

Sector

Industrials

ML Signal

HOLD

Logo Eledon Pharmaceuticals Inc.

ELDN

Eledon Pharmaceuticals Inc.

HOLD

Current Price

$1.51

Market Cap

123.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BIOX
ELDN
Founded
2001
2004
Country
Argentina
United States
Employees
N/A
N/A
Industry
Agricultural Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
109.2M
123.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BIOX
ELDN
Price
$1.31
$1.51
Analyst Decision
Buy
Strong Buy
Analyst Count
3
2
Target Price
$4.42
$8.50
AVG Volume (30 Days)
410.6K
942.3K
Earning Date
02-10-2026
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$318,158,904.00
N/A
Revenue This Year
$1.25
N/A
Revenue Next Year
$27.91
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.20
$1.35
52 Week High
$7.44
$4.98

Technical Indicators

Market Signals
Indicator
BIOX
ELDN
Relative Strength Index (RSI) 38.47 37.43
Support Level $1.30 $1.51
Resistance Level $1.65 $1.61
Average True Range (ATR) 0.09 0.09
MACD -0.02 0.04
Stochastic Oscillator 11.24 3.92

Price Performance

Historical Comparison
BIOX
ELDN

About BIOX Bioceres Crop Solutions Corp.

Bioceres Crop Solutions Corp is a fully integrated provider of crop productivity solutions, including seeds, seed traits, seed treatments, biologicals, high-value adjuvants, and fertilizers. The company has developed a multi-discipline and multi-product platform capable of providing solutions throughout the entire crop cycle, from pre-planting to transportation and storage. Some of the products offered by the company include fertilizers, inoculants, adjuvants, crop protection solutions, and seeds among others. Its operating segments are crop protection, which derives key revenue, seed and integrated products, and crop nutrition. Geographically, the majority of the company's revenue is generated from Argentina and the rest from Brazil, North America, Latin America, and other regions.

About ELDN Eledon Pharmaceuticals Inc.

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.

Share on Social Networks: